- Catalog ingredients or strategy
- Hydroquinone, kojic acid and niacinamide
- Provider
- CoreAge Rx
- Finished-product status
- Provider-described compounded prescription
- Source date
- October 8, 2026
What is being prescribed?
CoreAge Rx lists hydroquinone, kojic acid and niacinamide and markets the cream for dark spots and post-acne marks. These descriptions identify the product’s intended category. They do not diagnose the cause of a reader’s discoloration or confirm that the same treatment fits every kind of pigmentation.[source]
What supports the claims?
The finished compounded prescription is not FDA-approved. FDA’s compounding guidance distinguishes that status from the history or evidence of individual ingredients. This publication did not verify a controlled study establishing the exact Spot On blend’s efficacy or a guaranteed fading schedule.[source]
The detail that changes the comparison
Ask the clinician which diagnosis is being treated, the proposed concentrations and the planned review point. Clarify how to respond to irritation or an unexpected change in pigment. Do not extend or intensify use based on an advertisement or another person’s routine.[source]
Questions for the consultation
The complete cost requires the size of the dispensed product, consultation and renewal terms. Ask whether a treatment change affects the supply or charge. The public catalog is helpful for formulation discovery but is not a complete individualized quote.
Relevant alternatives
Agency Dark Spot Rx is a category alternative with formula-dependent ingredients, including hydroquinone-free options. A comparison should preserve that difference. The pigment-care guide explains what to ask before equating every brightening treatment.
Your questions, answered
Does every dark spot need a brightening cream?
No. The cause and appearance need evaluation. A new, changing or otherwise concerning lesion may need an in-person examination rather than a cosmetic treatment.
Was this cream tested by the publication?
No. This is a source-based review, without hands-on application, laboratory testing or independent medical review. Provider statements and broader ingredient evidence are identified separately.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx Help Center — What products does CoreAge Rx offer?Provider catalog, updated October 5, 2026; formulations and consultation terms
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations